Lung Cancer Therapeutics Market was valued at USD 36,929.9 Millionin 2021 and projected to grow at a CAGR of 13.5% during the forecast period 2020-2027 : MRFR

 

Market Highlights


Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain. The two types of lung cancers are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The NSCLC type accounts for almost 80% of the cancers with NSCLC representing the remaining. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four.

Almost 85% of cases of lung cancer market are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that passive smokers have a 20–30% increase in risk.

The treatments for lung cancer include surgery, chemotherapy, and radiotherapy with NSCLC responding better to surgery and SCLC usually responding better to chemotherapy and radiotherapy. The main drivers of stent lung cancer are the growing environmental pollution and smoking. The rise in the cases of lung cancers in females due to rising number of female smokers will drive the market up. Another driver is the greater screening rates with a sizable portion of lung cancer are detected during screening for other diseases.

Segmentation:

Global Lung Cancer Market has been segmented on the basis of types which comprises of push button Lung Cancer, pressure activated Lung Cancer and side button Lung Cancer. On the basis of end user, it comprises of hospitals & clinics, diagnostic centers and pathology laboratories, home diagnostics and other end users.

Regional Analysis:

The global market for Lung Cancer is growing steadily. The global lung cancer market on the basis of region comprises of North America, Europe, Asia Pacific and Middle East & Africa. The global market for Lung Cancer is growing with the CAGR of 13.5% during the forecast period from 2017-2023. NSCLC is the most common type of lung cancer globally. The global Lung Cancer market reached USD 36929.8 million in 2023 from 15219.7 million in 2016. Europe region captured the second largest market globally and is expected to reach USD 8,536.3 million by 2023 due to the growing demand and need for lung cancer drugs, and the growing prevalence of lung cancer.

Lung Cancer Market Players

·         Hoffmann-La Roche Ltd (Switzerland)

·         Novartis AG (Switzerland)

·         Pfizer (U.S.)

·         Merck & Co., Inc. (U.S.)

·         Bristol-Myers Squibb (U.S.)

·         Eli Lilly and Company (U.S.)

·         Sanofi (France)

among others are some key companies in the global Lung Cancer that are listed by MRFR for market research.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Comments

Post a Comment

Popular posts from this blog

Medical Implants Market Growth Drivers, Investment Opportunity, and Product Developments 2030 |MRFR

  Genetic Engineering Market Overview Genetic engineering or genetic modification is the manipulation of genes in an organism for enhancing its abilities. Genetic engineering is generally used by biotechnology and pharmaceutical companies, and clinical research organizations and is extensively used to treat cancer and other infectious disease. The genetic engineering market is expected to reach USD 5,811 Million by 2030 at 24.20% CAGR during the forecast period 2022-2030, asserts Market Research Future (MRFR). Drivers and Constraints Impacting the Market Technologies such as ZNF, CRISPR/Cas9, and TALEN are extensively used in gene therapy for various terminal illness and genetic disorders.   Such emerging technologies and innovations are likely to stimulate the market growth during the forecast period. Moreover, with the widespread use of genetic engineering in developed countries, application in the medicine industry, and special attention towards stem cells are pre...
Read more

Veterinary CBD Market Growth, size & share, Analysis, prediction research report and forecast to 2020-2027

  This impressive CAGR is possible due to the increasing number of household pets, the rising demand for humane practices in livestock management, and the easing of restrictions governing the use of CBD products to treat various ailments. The  Global Veterinary CBD Market   is poised to register a  CAGR of 129.97%  during the forecast period. The market for global veterinary CBD products is already very diverse with multiple channels of sale. Get Sample Report @ https://www.marketresearchfuture.com/sample_request/8138 SEGMENTATION ·          By Source ·          By Product ·          By Distribution Channel ·          By Region Regional Analysis The global veterinary CBD market is currently concentrated in North America but there is significant untapped potential in other regions due...
Read more

Smart Biosensors Market Type, Product, Key Players, Application and Growth Forecast to 2030 | MRFR

  Smart Biosensors Market Highlights Smart biosensors are medical devices used for chemical and biological analysis of a human body or any biological substance. Smart biosensors are advance and more effective than other traditional sensors. The increasing prevalence of diabetes in emerging economies, demand for advanced monitoring systems, and increasing awareness about advance biosensors are the major factors driving the growth of the global smart biosensors market. According to the International Diabetic Federation, about 415 million people across the globe were reported to have diabetes in 2015, and this number is expected to reach 642 million by 2040. It also stated that 98.4 million and 65.1 million diabetic population lived in China and India respectively. The Smart Biosensors market is anticipated to reach USD 23819.88 Million by 2030 at 6.90% CAGR during the forecast period 2022-2030. The rising cost of biosensors and unfavourable reimbursement polici...
Read more